Cerdulatinib
Catalog No. A14210
Cerdulatinib (PRT-062070)是多靶点酪氨酸激酶抑制剂,对JAK1/JAK2/JAK3/TYK2和Syk的IC50分别为12 nM/6 nM/8 nM/0.5 nM和32 nM。
Catalog Num | A14210 |
---|---|
M. Wt | 482 |
Formula | C20H28ClN7O3S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1369761-01-2 |
Synonyms | PRT062070, PRT2070, PRT-2070 |
SMILES | CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N.Cl |
Cerdulatinib (PRT-062070)是多靶点酪氨酸激酶抑制剂,对JAK1/JAK2/JAK3/TYK2和Syk的IC50分别为12 nM/6 nM/8 nM/0.5 nM和32 nM。
Targets
Target | Value |
---|---|
TYK2 | IC50: 0.5nM |
MST1 | IC50: 4nM |
ARK5 | IC50: 4nM |
MLK1 | IC50: 5nM |
Fms | IC50: 5nM |
AMPK | IC50: 6nM |
JAK2 | IC50: 6nM |
JAK3 | IC50: 8nM |
TBK1 | IC50: 10nM |
MARK1 | IC50: 10nM |
JAK1 | IC50: 12nM |
PAR1B-a | IC50: 13nM |
TSSK | IC50: 14nM |
MST2 | IC50: 15nM |
GCK | IC50: 18nM |
JNK3 | IC50: 18nM |
RSK2 | IC50: 20nM |
RSK4 | IC50: 28nM |
Syk | IC50: 32nM |
Chk1 | IC50: 42nM |
FLT4 | IC50: 51nM |
FLT3 | IC50: 90nM |
RET | IC50: 105nM |
ITK | IC50: 194nM |
In vitro (25°C) | DMSO | Warmed: 42 mg/mL (87.14 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 5% DMSO+corn oil | 2 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.75 mL | 103.73 mL | 207.47 mL |
0.5 mM | 4.15 mL | 20.75 mL | 41.49 mL |
1 mM | 2.07 mL | 10.37 mL | 20.75 mL |
5 mM | 0.41 mL | 2.07 mL | 4.15 mL |
*The above data is based on the productmolecular weight 482. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.